My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    J Exp Clin Cancer Res. 2008 Oct 17;27:52.

    Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).

    Miele E, Spinelli GP, Tomao F, Zullo A, De Marinis F, Pasciuti G, Rossi L, Zoratto F, Tomao S.

    Department of Experimental Medicine University of Rome Sapienza viale Regina Elena 324, Rome, Italy. evelina.miele@uniroma1.it

    Abstract

    PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physiological and biological phenomena. PET has found its application in common practice for the management of various cancers.Lung cancer is the most common cause of death for cancer in western countries.This review focuses on radiotracers used for PET scan with particular attention to Non Small Cell Lung Cancer diagnosis, staging, response to treatment and follow-up.

    PMID: 18928537 [PubMed - indexed for MEDLINE]PMCID: PMC2579910Free PMC Article

    Supplemental Content

    Click here to read Click here to read

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk